药企为公立医院薪酬改革提供支持,助力医改

2018-01-30 医药史立臣 MedSci原创

公立医院改革,是目前国家医改的重要工作。 公立医院改革目前一个非常重要的工作是对公立医院进行薪酬改革。

公立医院改革,是目前国家医改的重要工作。公立医院改革目前一个非常重要的工作是对公立医院进行薪酬改革。2017年底,人社部、财政部、国家卫计委、国家中医药局联合下发《关于扩大公立医院薪酬制度改革试点的通知》(人社部发〔2017〕92号,以下简称《通知》)。《通知》要求,各省(自治区、直辖市)结合本地实际,进一步积极、自主扩大公立医院薪酬制度改革试点范围,除按照人社部发〔2017〕10号文件《关于开展公立医院薪酬制度改革试点工作的指导意见》(以下简称《指导意见》)明确的试点城市外,其他城市至少选择1家公立医院开展薪酬制度改革试点,试点时间期限从发文起1年,并要求将制定的扩大试点工作方案于2018年1月底前报四部门备案。公立医院的薪酬改革,是让医生收入阳光有尊严。公立医院综合改革的主要任务,包括建立符合医疗卫生行业特点的人事薪酬制度,做到多劳多得、优绩优酬,推行同工同岗同酬制度改革,取消编制管理,打破编制内编制外不一样的薪酬待遇。但是,公立医院薪酬改革是个非常难的事情。公立医院薪酬制度改革本身就很难,一方面公立医院人事制度改革不动,人员进出还是受“编制”控制,还需要人事部门发文件的,在这种体

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1941858, encodeId=973c194185870, content=<a href='/topic/show?id=7282884558a' target=_blank style='color:#2F92EE;'>#薪酬改革#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88455, encryptionId=7282884558a, topicName=薪酬改革)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Tue Oct 09 00:16:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286934, encodeId=964212869347c, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Thu Feb 01 06:16:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553142, encodeId=fc79155314297, content=<a href='/topic/show?id=f983884456a' target=_blank style='color:#2F92EE;'>#薪酬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88445, encryptionId=f983884456a, topicName=薪酬)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd914357372, createdName=维他命, createdTime=Thu Feb 01 06:16:00 CST 2018, time=2018-02-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1941858, encodeId=973c194185870, content=<a href='/topic/show?id=7282884558a' target=_blank style='color:#2F92EE;'>#薪酬改革#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88455, encryptionId=7282884558a, topicName=薪酬改革)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Tue Oct 09 00:16:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286934, encodeId=964212869347c, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Thu Feb 01 06:16:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553142, encodeId=fc79155314297, content=<a href='/topic/show?id=f983884456a' target=_blank style='color:#2F92EE;'>#薪酬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88445, encryptionId=f983884456a, topicName=薪酬)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd914357372, createdName=维他命, createdTime=Thu Feb 01 06:16:00 CST 2018, time=2018-02-01, status=1, ipAttribution=)]
    2018-02-01 tidiq
  3. [GetPortalCommentsPageByObjectIdResponse(id=1941858, encodeId=973c194185870, content=<a href='/topic/show?id=7282884558a' target=_blank style='color:#2F92EE;'>#薪酬改革#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88455, encryptionId=7282884558a, topicName=薪酬改革)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd34186, createdName=wshxjq, createdTime=Tue Oct 09 00:16:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1286934, encodeId=964212869347c, content=<a href='/topic/show?id=ebac3442063' target=_blank style='color:#2F92EE;'>#医改#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34420, encryptionId=ebac3442063, topicName=医改)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3e9205, createdName=tidiq, createdTime=Thu Feb 01 06:16:00 CST 2018, time=2018-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553142, encodeId=fc79155314297, content=<a href='/topic/show?id=f983884456a' target=_blank style='color:#2F92EE;'>#薪酬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88445, encryptionId=f983884456a, topicName=薪酬)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccd914357372, createdName=维他命, createdTime=Thu Feb 01 06:16:00 CST 2018, time=2018-02-01, status=1, ipAttribution=)]
    2018-02-01 维他命

相关威廉亚洲官网

多家中药生产厂商因“短斤缺两”被CFDA官网曝光

2018年刚到,就有多家中药生产厂商因为“短斤缺两”被CFDA官网曝光。

中药产品想发展,就不要把价格做死

中药产品想发展,就不要把价格做死

40家中药厂所产人参被曝“农药残留超标、不合格”

有着“神草”之说的中药饮片人参被曝光“农药残留超标、不合格”,40家中药生产厂商上榜!

看看你是不是油腻的中年的医药人

看看你是不是油腻的中年的医药人

中国基层医疗市场潜力巨大

社区卫生服务市场增速远高于其他市场

按病种付费来了,药企是生存还是死亡?

进入2018年,要说医药行业最大的事件,莫过于按病种付费的全面推行。